At MITEC Medical, we are thrilled to announce that the Curaçao Medical Center has successfully completed the first FARAPULSE™ Pulsed Field Ablation (PFA) procedure in Curaçao, marking a significant milestone for the Caribbean region. This groundbreaking procedure is a testament to the collaborative efforts of Curaçao Medical Center, Boston Scientific, and MITEC Medical.
The introduction of the FARAPULSE™ PFA System, developed by Boston Scientific, is revolutionizing the treatment of atrial fibrillation (AFib). This technology selectively ablates cardiac tissue while minimizing the risk of damage to surrounding structures, enhancing both procedural safety and efficiency. Most importantly, it represents a major improvement in the quality of life for patients suffering from AFib.
This achievement places Curaçao alongside just three other locations in Latin America—Puerto Rico, Brazil, and Chile—where this state-of-the-art technology is available, making it a monumental step forward for cardiac care in the region.
We extend our deepest gratitude to the exceptional medical team at Curaçao Medical Center, including Dr. Arthur Liqui Lung, Dr. Fernando Di Tomasso, Dr. Olivier Witte, and Dr. José Miguel Torres Viera and their amazing nurse team, whose expertise and dedication made this milestone possible. We also acknowledge the unwavering support from Boston Scientific LATAM team, especially Mariano Linares, Mariano Plis, Guillermo Echevarría, Katherine Valverde, Luis Talero, Daniel Gaino, and our Field Clinical & Sales Manager, Emerlin Sánchez.
MITEC Medical is proud to play a crucial role in bringing this transformative technology to the Caribbean, and we are excited about the positive impact it will have on patient outcomes.
Thank you to everyone involved for your contributions to this remarkable achievement. Together, we are advancing the future of cardiac care in the Caribbean.
